Notably, the effect of the ASGR1 mutation on the risk of CAD is significantly greater than that on non-HDL-C levels, suggesting that the significant reduction in the risk of CAD is not entirely explained by the effect of ASGR1 mutations on non-HDL-C levels [22, 23]. Here, ASGR1 is linked to coronary artery disorder.